News from us and our partners

Tags

Topics

0 results

News
26 July, 2022
CinCor Pharma announces last patient randomized in Phase 2 HALO Trial and initiation of long-term extension study for Baxdrostat, a selective aldosterone synthase inhibitor, in uncontrolled hypertension
News
26 July, 2022
ReCor Medical and Otsuka Medical Devices announce primary endpoint met in the RADIANCE II U.S. pivotal trial of the Paradise™ System for the treatment of hypertension
News
26 July, 2022
Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera
News
26 July, 2022
Pi-Cardia receives FDA IDE approval for pivotal study with ShortCut(TM) device
News
15 July, 2022
Dr. Neal Gutterson joins Meiogenix board of directors
News
12 July, 2022
Tissium appoints Maria Sainz as Independent Board Member
News
12 July, 2022
GlycoEra AG expands Board of Directors and appoints Georges Gemayel, Ph.D., as Chair
News
12 July, 2022
Micropep raises €8.75M Series A1 for micropeptide crop protection
News
11 July, 2022
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
News
11 July, 2022
Inspirna raises $50 million in Series D financing
News
7 July, 2022
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
News
7 July, 2022
Biosyntia closes a €11.5 million round to launch world’s first bio-based vitamin B7
News
6 July, 2022
Nitrase Therapeutics expands leadership team with accomplished drug discovery and development executives
News
6 July, 2022
RefleXion announces closing of $125M debt facility for expanding cancer treatment
News
6 July, 2022
Skidmore, Owings & Merrill partners with Prometheus Materials to design zero-carbon building material
News
30 June, 2022
AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer

CinCor Pharma announces last patient randomized in Phase 2 HALO Trial and initiation of long-term extension study for Baxdrostat, a selective aldosterone synthase inhibitor, in uncontrolled hypertension

ReCor Medical and Otsuka Medical Devices announce primary endpoint met in the RADIANCE II U.S. pivotal trial of the Paradise™ System for the treatment of hypertension

Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera

Pi-Cardia receives FDA IDE approval for pivotal study with ShortCut(TM) device

Dr. Neal Gutterson joins Meiogenix board of directors

Tissium appoints Maria Sainz as Independent Board Member

GlycoEra AG expands Board of Directors and appoints Georges Gemayel, Ph.D., as Chair

Micropep raises €8.75M Series A1 for micropeptide crop protection

SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer

Inspirna raises $50 million in Series D financing

Genespire appoints Dr. Sabah Sallah as Chief Medical Officer

Biosyntia closes a €11.5 million round to launch world’s first bio-based vitamin B7

Nitrase Therapeutics expands leadership team with accomplished drug discovery and development executives

RefleXion announces closing of $125M debt facility for expanding cancer treatment

Skidmore, Owings & Merrill partners with Prometheus Materials to design zero-carbon building material

AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer